<DOC>
	<DOCNO>NCT01161069</DOCNO>
	<brief_summary>The purpose study evaluate safety toleration PF-03049423 follow multiple dose administration oral solution healthy young adult volunteer healthy elderly volunteer . The study also evaluate pharmacokinetics PF-03049423 multiple dose administration healthy young adult volunteer healthy elderly volunteer . The study also explore relationship blood pressure ( supine standing ) PF-03049423 concentration .</brief_summary>
	<brief_title>A Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03049423 In Healthy Adult Volunteers And Healthy Older Volunteers</brief_title>
	<detailed_description>The purpose investigation evaluate safety tolerability investigational new drug , PF-03049423 , dose two week healthy young healthy old subject .</detailed_description>
	<criteria>Healthy person , male female . For healthy young adult cohort , subject must 18 50 year old , inclusive . For healthy elderly adult cohort , subject must 51 99 year old , inclusive . Body Mass Index ( BMI ) 18 35 ; total body weight &gt; 50 kg ( 110 lb ) Subjects clinically significant medical condition . Women nonchild bear potential . Subjects know medical history hearing loss/disability nonarteritic ischemic optic neuropathy . A positive urine drug screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>phase 1</keyword>
	<keyword>healthy young adult volunteer</keyword>
	<keyword>healthy elderly adult volunteer</keyword>
</DOC>